Author

Bader Zarrouki

AstraZeneca (Sweden)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Abhishek NagiD· 1 shared Agnes BonifaciusiD· 1 shared Andrea AhnmarkiD· 1 shared Andrew Robert HarperiD· 1 shared Artemis Gavriil· 1 shared Benjamin ChallisiD· 1 shared Bilada BilicaniD· 1 shared Britta Eiz‐VesperiD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Abhishek NagORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ENTPD3-specific CAR Regulatory T cells for Local Immune Control in T1D

Tom Pieper, Tobias Riët, Valerie Saetzler, Katharina F. Bergerhoff, Jenny L. McGovern, Louise Delsing, Mark A. Atkinson, Tracey A. Lodie, Lutz Jermutus, Fatih Noyan, Michael Hust, Irina Kusmartseva, Maike Hagedorn, Maren Lieber, Pierre Henschel, , Elmar Jaeckel

This paper develops ENTPD3-specific CAR Tregs to control T1D by targeting beta cells and shows their efficacy in preventing disease progression in a mouse model.

bioRxiv · Nov 12, 2024 · PreprintImmunology

Human genetic evidence supports MAP3K15 inhibition as a therapeutic strategy for diabetes

Abhishek Nag, Ryan S. Dhindsa, Andrew Robert Harper, Dimitrios Vitsios, Andrea Ahnmark, Bilada Bilican, Katja Madeyski-Bengtson, Bader Zarrouki, Quanli Wang, Katherine R. Smith, David M. Smith, Benjamin Challis, Dirk S. Paul, Mohammad Bohlooly‐Y, Mike Snowden, , Slavé Petrovski

The paper identifies MAP3K15 as a protective gene for diabetes through genetic analysis and shows its inhibition could be a therapeutic strategy.

medRxiv · Nov 14, 2021 · PreprintGenetic & Genomic Medicine